Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 4 Chronic Hepatitis C”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02956629
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 282
Large-scale testing (Phase 3)Study completedNCT02250807
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis CGenotype 4 Chronic Hepatitis C
Janssen R&D Ireland 40
Testing effectiveness (Phase 2)Study completedNCT02593162
What this trial is testing

Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Viral InfectionChronic Hepatitis CHepatitis C (HCV)+1 more
Trek Therapeutics, PBC 16
Testing effectiveness (Phase 2)Study completedNCT01010646
What this trial is testing

Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 84
Large-scale testing (Phase 3)WithdrawnNCT01797848
What this trial is testing

Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT02243280
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 174
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Testing effectiveness (Phase 2)Study completedNCT01125189
What this trial is testing

Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 558
Large-scale testing (Phase 3)Study completedNCT02446717
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV+1 more
AbbVie 141
Post-approval studies (Phase 4)Study completedNCT00277862
What this trial is testing

Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4

Who this might be right for
Hepatitis C
Ain Shams University 280
Testing effectiveness (Phase 2)Study completedNCT01648140
What this trial is testing

Dose Ranging of GSK2336805 in Combination Therapy

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 286
Testing effectiveness (Phase 2)Study completedNCT01057667
What this trial is testing

RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 168
Large-scale testing (Phase 3)Study completedNCT02105701
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)

Who this might be right for
Hepatitis C Infection
Merck Sharp & Dohme LLC 420
Large-scale testing (Phase 3)Study completedNCT02105688
What this trial is testing

An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 301
Testing effectiveness (Phase 2)Study completedNCT01932762
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 98
Large-scale testing (Phase 3)WithdrawnNCT01871662
What this trial is testing

Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Rottapharm
Not applicableStudy completedNCT02817594
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 51
Large-scale testing (Phase 3)Study completedNCT01838590
What this trial is testing

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 103
Testing effectiveness (Phase 2)Study completedNCT01782495
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 129
Large-scale testing (Phase 3)WithdrawnNCT01447394
What this trial is testing

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb
Next Page